STOCK TITAN

Innate Pharma Sa Stock Price, News & Analysis

IPHA Nasdaq

Welcome to our dedicated page for Innate Pharma Sa news (Ticker: IPHA), a resource for investors and traders seeking the latest updates and insights on Innate Pharma Sa stock.

Innate Pharma SA (IPHA) is a clinical-stage biotechnology leader advancing immuno-oncology therapies through innovative antibody development. This page serves as the definitive source for official company announcements and curated news coverage.

Key updates include clinical trial milestones, regulatory developments, strategic collaborations, and scientific advancements. Investors and researchers will find timely information on NK cell engager therapeutics, partnership expansions with major biopharma entities, and progress across the company's oncology pipeline.

All content is sourced directly from verified corporate communications and reputable financial analysis. Bookmark this page for streamlined access to IPHA's latest developments in harnessing innate immunity for cancer treatment breakthroughs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.96%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.8%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.66%
Tags
management
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.43%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.31%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.66%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.15%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
18.39%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.81%
Tags
conferences

FAQ

What is the current stock price of Innate Pharma Sa (IPHA)?

The current stock price of Innate Pharma Sa (IPHA) is $1.815 as of June 30, 2025.

What is the market cap of Innate Pharma Sa (IPHA)?

The market cap of Innate Pharma Sa (IPHA) is approximately 165.9M.
Innate Pharma Sa

Nasdaq:IPHA

IPHA Rankings

IPHA Stock Data

165.88M
92.18M
0.3%
0.55%
Biotechnology
Healthcare
Link
France
Marseille